Primary Site >> Stomach Cancer

Gene >> CA9

  • 1989
  • 1997
  • 2005
  • 2011
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: [Radio- and radio-chemosensitivity of human head and neck cancer cell line detected by human tumor clonogenic assay].
PMID: 2483254
Ref: Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts.
PMID: 9024293
Ref: Expression of carbonic anhydrase 9 at the invasion front of gastric cancers.
PMID: 15951534
Ref: Is the hypoxia-inducible factor pathway important in gastric cancer?
PMID: 16290133
Ref: Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.
PMID: 21281785
Ref: Diagnostic and prognostic significance of CA IX and suPAR in gastric cancer.
PMID: 23512428
Ref: High monocarboxylate transporter 4 protein expression in stromal cells predicts adverse survival in gastric cancer.
PMID: 25374230
Ref: Silencing of hypoxia-inducible tumor suppressor lysyl oxidase gene by promoter methylation activates carbonic anhydrase IX in nasopharyngeal carcinoma.
PMID: 25520868
Ref: CREB is a key negative regulator of carbonic anhydrase IX (CA9) in gastric cancer.
PMID: 25843777
Ref: A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
PMID: 26685087
Ref: Target research on tumor biology characteristics of mir-155-5p regulation on gastric cancer cell.
PMID: 27113301
Ref: Collagen gel droplet-embedded culture drug sensitivity testing in squamous cell carcinoma cell lines derived from human oral cancers: Optimal contact concentrations of cisplatin and fluorouracil.
PMID: 28105171
Ref: In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell Lines.
PMID: 28819369
Ref: Overexpression of Tie2 is associated with poor prognosis in patients with gastric cancer.
PMID: 29849805
Ref: Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
PMID: 29851704